What is the dosing for Metronidazole (Flagyl) vaginal cream?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 19, 2025 • View editorial policy

From the Guidelines

Metronidazole vaginal cream (0.75%) should be prescribed as one full applicator (5 g) intravaginally, once a day for 5 days. This dosing regimen is based on the Centers for Disease Control and Prevention's guidelines for the treatment of bacterial vaginosis, as outlined in the 2002 sexually transmitted diseases treatment guidelines 1. The recommended regimen is equally efficacious to oral metronidazole and is a preferred option for patients who may have difficulty with oral medication or prefer a topical treatment.

Some key points to consider when prescribing metronidazole vaginal cream include:

  • Patients should be advised to avoid consuming alcohol during treatment with metronidazole and for 24 hours thereafter to prevent a disulfiram-like reaction 1
  • Clindamycin cream and ovules are oil-based and might weaken latex condoms and diaphragms, so patients should be cautioned about this potential interaction 1
  • The vaginal cream should be inserted deep into the vagina using the provided applicator, and patients should complete the full course of treatment even if symptoms improve before completion
  • Common side effects may include vaginal irritation, discharge, or a metallic taste in the mouth

It's also important to note that metronidazole works by directly killing anaerobic bacteria and protozoa that cause bacterial vaginosis or trichomoniasis by interfering with their DNA synthesis. If symptoms persist after treatment, patients should follow up with their healthcare provider as an alternative treatment may be needed. The guidelines also recommend that patients be advised to avoid sexual intercourse during treatment, and tampons should not be used 1.

From the FDA Drug Label

The recommended dose is one applicator full of metronidazole vaginal gel (approximately 5 grams containing approximately 37.5 mg of metronidazole) intravaginally once or twice a day for 5 days. The dosing for metronidazole vaginal cream is not explicitly stated in the provided label, which only mentions metronidazole vaginal gel.

  • The label does provide dosing information for the gel formulation, but it does not address the cream formulation. Since the label does not directly address metronidazole vaginal cream dosing, no conclusion can be drawn about the dosing for this specific formulation 2.

From the Research

Metronidazole Vaginal Cream Dosing

  • The dosing for metronidazole vaginal cream is not explicitly stated in the provided studies, but metronidazole vaginal gel dosing is mentioned as 0.75% metronidazole vaginal gel 5 g twice daily for 5 days 3, 4.
  • Clindamycin vaginal cream is mentioned as an alternative treatment option, with a dosing of 2% clindamycin vaginal cream 5 g once daily for 7 days 3, 5, 4, 6.
  • Oral metronidazole is also mentioned as a treatment option, with dosing ranging from 250 mg orally three times a day for 7 days to 500 mg orally twice daily for 7 days 5, 4, 6.
  • It is essential to note that the provided studies do not specifically address metronidazole vaginal cream dosing, but rather metronidazole vaginal gel and clindamycin vaginal cream dosing 3, 5, 4, 6.

Treatment Options

  • Metronidazole vaginal gel, oral metronidazole, and clindamycin vaginal cream are all effective treatment options for bacterial vaginosis 3, 5, 4, 6.
  • The choice of treatment may depend on patient preference, symptom severity, and potential side effects 3, 5, 4, 6.
  • It is crucial to follow the recommended dosing and treatment duration to ensure effective treatment and minimize the risk of side effects 3, 5, 4, 6.

Side Effects and Complications

  • Posttreatment vulvovaginal candidiasis is a potential complication of treating bacterial vaginosis, with rates ranging from 12.5% to 30.4% depending on the treatment option 3.
  • Other side effects, such as nausea, headache, and vomiting, may also occur 7.
  • It is essential to monitor patients for potential side effects and complications during and after treatment 3, 5, 4, 7, 6.

References

Research

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Research

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Research

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.